|
Sign In to gain access to subscriptions and/or personal tools.
|
Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus
P Rahman
D D Gladman
Centre for Prognosis Studies in the Rheumatic Diseases, The Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada
M B Urowitz
Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University Health Network, Room 1-319 Main Pavilion, 399 Bathurst St, Toronto, Ontario, Canada M5T 2S8,m.urowitz{at}utoronto.ca
D Hallett
L S Tam
Centre for Prognosis Studies in the Rheumatic Diseases, The Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada
The aim of this study was to determine whether early damage accrued in SLE as measured by the SLICC/ACR Damage Index predicts mortality in an inception cohort of lupus patients that have been followed prospectively in a single centre. SLE patients from the University of Toronto Lupus Clinic presenting within 1 y of their diagnosis prior to 1988 were included. This enabled all patients to be potentially followed for at least 10 y. Yearly SLICC/ACR Damage Index scores were determined for each patient. Early damage was defined as a score 1 and no damage as a score of 0 at the initial assessment. Log rank test was used to compare the survival experience between those with and without damage, with all patients being censored at 10 y. Two-hundred and sixty-three patients were identified in this inception cohort who were followed for 10 y. One-hundred and ninety patients (72%) had a SLICC/ACR Damage Index score of 0 (no damage) while 73 patients (28%) had at least one SLICC/ACR Damage Index item scored (early damage). Twenty-five percent of lupus patients who exhibited damage at their first SLICC/ACR Damage Index assessment died within 10 y of their illness as compared to only 7.3% who had no early damage (log rank P-value = 0.0002). SLE patients who died within 10 y were more likely to have renal damage (P = 0.013), and a trend toward more cardiovascular disease (P = 0.056), compared to patients who were alive. Early damage as reflected by the initial SLICC/ACR Damage Index is associated with a higher rate of mortality.
Key Words: SLE • damage predictor
Lupus, Vol. 10, No. 2,
93-96 (2001)
DOI: 10.1191/096120301670679959
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
L. Gonzalez, G. Pons-Estel, J Zhang, L. Vila, J. Reveille, G. Alarcon, and for the LUMINA study group
Time to neuropsychiatric damage occurrence in LUMINA (LXVI): a multi-ethnic lupus cohort
Lupus,
August 1, 2009;
18(9):
822 - 830.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. A. Chambers, E. Allen, A. Rahman, and D. Isenberg
Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years
Rheumatology,
June 1, 2009;
48(6):
673 - 675.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C Gordon, G Bertsias, J P A Ioannidis, J Boletis, S Bombardieri, R Cervera, C Dostal, J Font, I-M Gilboe, F Houssiau, et al.
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus
Ann Rheum Dis,
April 1, 2009;
68(4):
470 - 476.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G K Bertsias, J P A Ioannidis, J Boletis, S Bombardieri, R Cervera, C Dostal, J Font, I M Gilboe, F Houssiau, T Huizinga, et al.
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints
Ann Rheum Dis,
April 1, 2009;
68(4):
477 - 483.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Cardoso, F. Signorelli, J. Papi, and G. Salles
Initial and accrued damage as predictors of mortality in Brazilian patients with systemic lupus erythematosus: a cohort study
Lupus,
November 1, 2008;
17(11):
1042 - 1048.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Negron, M. Molina, A. Mayor, V. Rodriguez, and L. Vila
Factors associated with metabolic syndrome in patients with systemic lupus erythematosus from Puerto Rico
Lupus,
April 1, 2008;
17(4):
348 - 354.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S-W Lee, M-C Park, Y-B Park, and S-K Lee
E/E' ratio is more sensitive than E/A ratio for detection of left ventricular diastolic dysfunction in systemic lupus erythematosus
Lupus,
March 1, 2008;
17(3):
195 - 201.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Zonana-Nacach, P. Yanez, F.J. Jimenez-Balderas, and A. Camargo-Coronel
Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus
Lupus,
December 1, 2007;
16(12):
997 - 1000.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M.B. Urowitz, D. Gladman, D. Ibanez, P. Fortin, J. Sanchez-Guerrero, S. Bae, A. Clarke, S. Bernatsky, C. Gordon, J. Hanly, et al.
Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort
Lupus,
September 1, 2007;
16(9):
731 - 735.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A.M. Bertoli, L.M. Vila, M. Apte, B.J. Fessler, H.M. Bastian, J.D. Reveille, and G.S. Alarcon
Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage
Lupus,
June 1, 2007;
16(6):
410 - 417.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C A Hitchon and C A Peschken
Sm antibodies increase risk of death in systemic lupus erythematosus
Lupus,
March 1, 2007;
16(3):
186 - 194.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P. D. Ziakas, U. G. Dafni, S. Giannouli, A. G. Tzioufas, and M. Voulgarelis
Thrombocytopaenia in lupus as a marker of adverse outcome--seeking Ariadne's thread
Rheumatology,
October 1, 2006;
45(10):
1261 - 1265.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C A Pineau, S Bernatsky, M Abrahamowicz, C Neville, I Karp, and A E Clarke
A comparison of damage accrual across different calendar periods in systemic lupus erythematosus patients
Lupus,
September 1, 2006;
15(9):
590 - 594.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R Prasad, D Ibanez, D Gladman, and M Urowitz
Anti-dsDNA and anti-Sm antibodies do not predict damage in systemic lupus erythematosus
Lupus,
May 1, 2006;
15(5):
285 - 291.
[Abstract]
[PDF]
|
|
|
|
|
|
|
H I Brunner, A Bishnoi, A C Barron, L J Houk, A Ware, Y Farhey, A B Mongey, C F Strife, T B Graham, and M H Passo
Disease outcomes and ovarian function of childhood-onset systemic lupus erythematosus
Lupus,
April 1, 2006;
15(4):
198 - 206.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M M A Fernando and D A Isenberg
How to monitor SLE in routine clinical practice
Ann Rheum Dis,
April 1, 2005;
64(4):
524 - 527.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G Ruiz-Irastorza, M-V Egurbide, A Martinez-Berriotxoa, J Ugalde, and C Aguirre
Antiphospholipid antibodies predict early damage in patients with systemic lupus erythematosus
Lupus,
December 1, 2004;
13(12):
900 - 905.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. Mikdashi and B. Handwerger
Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort
Rheumatology,
December 1, 2004;
43(12):
1555 - 1560.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J Schiffenbauer and L S Simon
Randomized controlled trials in systemic lupus erythematosus: what has been done and what do we need to do?
Lupus,
May 1, 2004;
13(5):
398 - 405.
[Abstract]
[PDF]
|
|
|
|
|
|
|
V Strand
Clinical trial design in systemic lupus erythematosus: lessons learned and future directions
Lupus,
May 1, 2004;
13(5):
406 - 411.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C S. Hallengren, O Nived, and G Sturfelt
Outcome of incomplete systemic lupus erythematosus after 10 years
Lupus,
February 1, 2004;
13(2):
85 - 88.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. S. Alarcon, J. M. Roseman, G. McGwin Jr, A. Uribe, H. M. Bastian, B. J. Fessler, B. A. Baethge, A. W. Friedman, and J. D. Reveille
Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damage
Rheumatology,
February 1, 2004;
43(2):
202 - 205.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Isenberg, E. Allen, V. Farewell, M. R. Ehrenstein, M. G. Hanna, I. E. Lundberg, C. Oddis, C. Pilkington, P. Plotz, D. Scott, et al.
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease
Rheumatology,
January 1, 2004;
43(1):
49 - 54.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S Sundaramurthy, T M Bush, C M Neuwelt, and M M Ward
Time perspective predicts the progression of permanent organ damage in patients with systemic lupus erythematosus
Lupus,
June 1, 2003;
12(6):
443 - 448.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. Jonsen, A. A. Bengtsson, O. Nived, B. Ryberg, and G. Sturfelt
Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality
Rheumatology,
November 1, 2002;
41(11):
1308 - 1312.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Gordon
Long-term complications of systemic lupus erythematosus
Rheumatology,
October 1, 2002;
41(10):
1095 - 1100.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y Molad, A Gorshtein, A J Wysenbeek, D Guedj, R Majadla, A Weinberger, and M Amit-Vazina
Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort{
Lupus,
June 1, 2002;
11(6):
356 - 361.
[Abstract]
[PDF]
|
|
|
|
|
|
|
N A Dayal, C Gordon, L Tucker, and D A Isenberg
The SLICC Damage Index: past, present and future
Lupus,
April 1, 2002;
11(4):
261 - 265.
[PDF]
|
|
|
|
|
